How to Buy Auro Laboratories Ltd Shares?
You can easily buy the stocks/shares of Auro Laboratories Ltd (AUROLAB) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Auro Laboratories Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of AUROLAB as on 15th May 2025 is ₹259.28What is the return on Auro Laboratories Ltd share?
The past returns of Auro Laboratories Ltd (AUROLAB) share are- Past 1 week: N/A
- Past 1 month: -92.92
- Past 3 months: 20.97
- Past 6 months: 18.76
- Past 1 year: 27.64
- Past 3 years: 207.43
- Past 5 years: 426.30
What is the Dividend yield % on Auro Laboratories Ltd share?
The current dividend yield of Auro Laboratories Ltd (AUROLAB) is N/AWhat is the Market Cap of Auro Laboratories Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Auro Laboratories Ltd (AUROLAB) is ₹170.02Cr as of 15th May 2025What is the 52 Week High and Low of Auro Laboratories Ltd?
The 52-week high and low of Auro Laboratories Ltd (AUROLAB) is ₹300 and ₹156.40.What is the PE and PB ratio of Auro Laboratories Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Auro Laboratories Ltd are 92.40 and 4.05 respectively.Which sector does Auro Laboratories Ltd belong to?
Auro Laboratories Ltd (AUROLAB) belongs to the Health Care sector & Pharmaceuticals sub-sector.What are the peers or stocks similar to Auro Laboratories Ltd?
The peers or stocks similar to Auro Laboratories Ltd are: and many others.Can't decide whether or not to buy Auro Laboratories Ltd?
Worry no more! Login to Tickertape and check out Auro Laboratories Ltd (AUROLAB) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Auro Laboratories Ltd?
The 52-week high and low of Auro Laboratories Ltd (AUROLAB) is ₹300 and ₹156.40.1. Test Stocks FAQ for Auro Laboratories Ltd Shares?
You can easily buy the stocks/shares of Auro Laboratories Ltd (AUROLAB) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Auro Laboratories Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of AUROLAB as on 15th May 2025 is ₹259.28
Auro Laboratories Ltd
AUROLAB Share Price
259.281.20% (+3.08)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
AUROLAB Performance & Key Metrics
AUROLAB Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 109.69 | 4.05 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.21 | 6.66 | 0.83% |
AUROLAB Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
AUROLAB Company Profile
Auro Laboratories Limited is engaged in the business of bulk drugs. It manufactures active pharmaceutical ingredients (APIs), intermediates and generic formulations.
SUNPHARMA
PE Ratio
37.00
37.00
1Y Return
11.72%
11.72%
Buy Reco %
89.19
89.19
CIPLA
PE Ratio
23.03
23.03
1Y Return
2.55%
2.55%
Buy Reco %
71.05
71.05
DRREDDY
PE Ratio
20.02
20.02
1Y Return
11.76%
11.76%
Buy Reco %
82.05
82.05
TORNTPHARM
PE Ratio
57.53
57.53
1Y Return
13.13%
13.13%
Buy Reco %
67.74
67.74
MANKIND
PE Ratio
49.29
49.29
1Y Return
6.30%
6.30%
Buy Reco %
—
—
AUROLAB Sentiment Analysis
AUROLAB Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
AUROLAB Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
AUROLAB Stock Growth Drivers
AUROLAB Stock Growth Drivers
4Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
AUROLAB Stock Challenges
AUROLAB Stock Challenges
0
Hmm, looks like there are nochallenges
AUROLAB Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
AUROLAB Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
AUROLAB
AUROLAB
Income
Balance Sheet
Cash Flow
Annual Normal View
AUROLAB Income Statement
AUROLAB Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 36.00 | 41.30 | 47.78 | 44.76 | 55.01 | 51.96 | 53.83 | 55.14 | 20.05 | 20.06 | ||||||||||
Raw Materials | 20.08 | 24.66 | 30.39 | 23.99 | 27.64 | 33.76 | 37.30 | 29.04 | 15.99 | 15.98 | ||||||||||
| Power & Fuel Cost | 1.29 | 1.48 | 1.64 | 1.69 | 1.60 | 1.67 | 2.08 | 2.43 | ||||||||||||
| Employee Cost | 2.72 | 2.80 | 2.87 | 3.48 | 3.64 | 3.70 | 3.76 | 3.91 | ||||||||||||
| Selling & Administrative Expenses | 2.52 | 3.27 | 4.18 | 5.03 | 5.84 | 5.86 | 4.73 | 7.31 | ||||||||||||
| Operating & Other expenses | 4.44 | 2.23 | 0.75 | 3.33 | 4.29 | 1.25 | 0.63 | 0.28 | ||||||||||||
EBITDA | 4.95 | 6.86 | 7.95 | 7.24 | 12.00 | 5.72 | 5.33 | 12.17 | 4.06 | 4.08 | ||||||||||
| Depreciation/Amortization | 0.86 | 0.93 | 1.01 | 1.02 | 1.04 | 1.02 | 1.07 | 1.09 | 1.10 | 1.10 | ||||||||||
| PBIT | 4.09 | 5.93 | 6.94 | 6.22 | 10.96 | 4.70 | 4.26 | 11.08 | 2.96 | 2.98 | ||||||||||
| Interest & Other Items | 1.18 | 1.21 | 0.87 | 0.58 | 0.46 | 0.83 | 0.81 | 0.74 | 1.08 | 1.08 | ||||||||||
| PBT | 2.91 | 4.72 | 6.07 | 5.64 | 10.50 | 3.87 | 3.45 | 10.34 | 1.88 | 1.90 | ||||||||||
| Taxes & Other Items | 2.11 | 1.19 | 1.67 | 1.58 | 3.32 | 1.03 | 1.00 | 2.55 | 0.04 | 0.35 | ||||||||||
| Net Income | 0.80 | 3.53 | 4.40 | 4.06 | 7.18 | 2.84 | 2.45 | 7.79 | 1.84 | 1.55 | ||||||||||
| EPS | 1.28 | 5.66 | 7.06 | 6.51 | 11.52 | 4.56 | 3.93 | 12.50 | 2.95 | 2.49 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
AUROLAB Company Updates
AUROLAB Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
AUROLAB Past Performance & Peer Comparison
AUROLAB Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Auro Laboratories Ltd | 92.40 | 4.05 | — |
| Sun Pharmaceutical Industries Ltd | 37.00 | 6.03 | 0.95% |
| Cipla Ltd | 23.03 | 4.53 | 1.06% |
| Dr Reddy's Laboratories Ltd | 20.02 | 4.01 | 0.59% |
AUROLAB Stock Price Comparison
Compare AUROLAB with any stock or ETFCompare AUROLAB with any stock or ETF
AUROLAB
AUROLAB Holdings
AUROLAB Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
AUROLAB Promoter Holdings Trend
AUROLAB Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
AUROLAB Institutional Holdings Trend
AUROLAB Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
AUROLAB Shareholding Pattern
AUROLAB Shareholding Pattern
AUROLAB Shareholding History
AUROLAB Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing AUROLAB stock
smallcases containing AUROLAB stock
Looks like this stock is not in any smallcase yet.
AUROLAB Events
AUROLAB Events
AUROLAB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AUROLAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
AUROLAB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
AUROLAB has not given any dividends in last 5 years
AUROLAB Dividends
AUROLAB Dividends
Hmm, looks like data is unavailable here. Please come back after some timeAUROLAB Stock News & Opinions
AUROLAB Stock News & Opinions
Articles & Videos
Earnings
Auro Laboratories standalone net profit declines 83.19% in the March 2025 quarter
Net profit of Auro Laboratories declined 83.19% to Rs 0.39 crore in the quarter ended March 2025 as against Rs 2.32 crore during the previous quarter ended March 2024. Sales declined 38.64% to Rs 7.40 crore in the quarter ended March 2025 as against Rs 12.06 crore during the previous quarter ended March 2024. For the full year,net profit declined 76.38% to Rs 1.84 crore in the year ended March 2025 as against Rs 7.79 crore during the previous year ended March 2024. Sales declined 63.83% to Rs 19.40 crore in the year ended March 2025 as against Rs 53.64 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales7.4012.06 -39 19.4053.64 -64 OPM %10.9519.98 -17.5319.89 - PBDT0.643.13 -80 2.9811.43 -74 PBT0.352.85 -88 1.8810.34 -82 NP0.392.32 -83 1.847.79 -76 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Auro Laboratories revises board meeting date
Auro Laboratories has revised the meeting of the Board of Directors which was scheduled to be held on 23 May 2025. The meeting will now be held on 30 May 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Auro Laboratories announces board meeting date
Auro Laboratories will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Earnings
Auro Laboratories standalone net profit declines 98.17% in the December 2024 quarter
Net profit of Auro Laboratories declined 98.17% to Rs 0.05 crore in the quarter ended December 2024 as against Rs 2.73 crore during the previous quarter ended December 2023. Sales declined 83.04% to Rs 3.05 crore in the quarter ended December 2024 as against Rs 17.98 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales3.0517.98 -83 OPM %14.7522.64 - PBDT0.344.05 -92 PBT0.073.78 -98 NP0.052.73 -98 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Auro Laboratories to hold board meeting
Auro Laboratories will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Auro Laboratories standalone net profit declines 81.73% in the September 2024 quarter
Net profit of Auro Laboratories declined 81.73% to Rs 0.36 crore in the quarter ended September 2024 as against Rs 1.97 crore during the previous quarter ended September 2023. Sales declined 76.88% to Rs 3.10 crore in the quarter ended September 2024 as against Rs 13.41 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3.1013.41 -77 OPM %23.2322.60 - PBDT0.753.00 -75 PBT0.482.73 -82 NP0.361.97 -82 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Auro Laboratories to hold board meeting
Auro Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Auro Laboratories to announce Quarterly Result
Auro Laboratories will hold a meeting of the Board of Directors of the Company on 9 August 2024Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 2.91%, vs industry avg of 9.02%
Over the last 5 years, market share stayed at 0.01%
Over the last 5 years, net income has grown at a yearly rate of 12.1%, vs industry avg of 15.29%